About the brand ❤️
Sputnik V is a Russian vaccine developed to prevent COVID-19 by the Gamaleya National Research Center, with support from the Russian Direct Investment Fund. Officially known as Gam-COVID-Vac, it was registered in Russia in August 2020, becoming the first COVID-19 vaccine registered for use in a country. The vaccine uses two different human adenovirus vectors administered in separate doses to stimulate an immune response against SARS-CoV-2. Sputnik V was subsequently authorized in numerous countries and became part of Russia's international vaccine diplomacy efforts.
Founded: 2020
Headquarters:
Gamaleya National Research Center, 18 Gamaleya Street, Moscow 123098, Russian Federation
Owner: Russian Direct Investment Fund (RDIF)
https://sputnikvaccine.com/
Download PNG
